These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16829630)

  • 1. Therapeutic hypercapnia prevents chronic hypoxia-induced pulmonary hypertension in the newborn rat.
    Kantores C; McNamara PJ; Teixeira L; Engelberts D; Murthy P; Kavanagh BP; Jankov RP
    Am J Physiol Lung Cell Mol Physiol; 2006 Nov; 291(5):L912-22. PubMed ID: 16829630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic hypercapnia prevents bleomycin-induced pulmonary hypertension in neonatal rats by limiting macrophage-derived tumor necrosis factor-α.
    Sewing AC; Kantores C; Ivanovska J; Lee AH; Masood A; Jain A; McNamara PJ; Tanswell AK; Jankov RP
    Am J Physiol Lung Cell Mol Physiol; 2012 Jul; 303(1):L75-87. PubMed ID: 22582114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercapnia attenuates hypoxic pulmonary hypertension by inhibiting lung radical injury.
    Chovanec M; Novotná J; Wilhelm J; Hampl V; Vízek M; Herget J
    Physiol Res; 2009; 58 Suppl 2():S79-S86. PubMed ID: 20131939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of SB 217242 on hypoxia-induced cardiopulmonary changes in the high altitude-sensitive rat.
    Underwood DC; Bochnowicz S; Osborn RR; Luttmann MA; Louden CS; Hart TK; Elliott JD; Hay DW
    Pulm Pharmacol Ther; 1999; 12(1):13-26. PubMed ID: 10208832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained therapeutic hypercapnia attenuates pulmonary arterial Rho-kinase activity and ameliorates chronic hypoxic pulmonary hypertension in juvenile rats.
    Peng G; Ivanovska J; Kantores C; Van Vliet T; Engelberts D; Kavanagh BP; Enomoto M; Belik J; Jain A; McNamara PJ; Jankov RP
    Am J Physiol Heart Circ Physiol; 2012 Jun; 302(12):H2599-611. PubMed ID: 22505643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic hypercapnia prevents inhaled nitric oxide-induced right-ventricular systolic dysfunction in juvenile rats.
    Dunlop K; Gosal K; Kantores C; Ivanovska J; Dhaliwal R; Desjardins JF; Connelly KA; Jain A; McNamara PJ; Jankov RP
    Free Radic Biol Med; 2014 Apr; 69():35-49. PubMed ID: 24423485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of reactive oxygen species to the pathogenesis of pulmonary arterial hypertension.
    Jernigan NL; Naik JS; Weise-Cross L; Detweiler ND; Herbert LM; Yellowhair TR; Resta TC
    PLoS One; 2017; 12(6):e0180455. PubMed ID: 28666030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hypercapnia downregulates arginase expression and activity and increases pulmonary arterial smooth muscle relaxation in the newborn rat.
    Belik J; Stevens D; Pan J; Shehnaz D; Ibrahim C; Kantores C; Ivanovska J; Grasemann H; Jankov RP
    Am J Physiol Lung Cell Mol Physiol; 2009 Oct; 297(4):L777-84. PubMed ID: 19666777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for platelet-derived growth factor beta-receptor in a newborn rat model of endothelin-mediated pulmonary vascular remodeling.
    Jankov RP; Kantores C; Belcastro R; Yi S; Ridsdale RA; Post M; Tanswell AK
    Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1162-70. PubMed ID: 15722379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic hypercapnia inhibits hypoxic pulmonary vascular remodeling.
    Ooi H; Cadogan E; Sweeney M; Howell K; O'Regan RG; McLoughlin P
    Am J Physiol Heart Circ Physiol; 2000 Feb; 278(2):H331-8. PubMed ID: 10666061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice.
    Jiang L; Konishi H; Nurwidya F; Satoh K; Takahashi F; Ebinuma H; Fujimura K; Takasu K; Jiang M; Shimokawa H; Bujo H; Daida H
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1972-9. PubMed ID: 27493099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAY 41-2272, a direct activator of soluble guanylate cyclase, reduces right ventricular hypertrophy and prevents pulmonary vascular remodeling during chronic hypoxia in neonatal rats.
    Deruelle P; Balasubramaniam V; Kunig AM; Seedorf GJ; Markham NE; Abman SH
    Biol Neonate; 2006; 90(2):135-44. PubMed ID: 16582538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactive fraction of Rhodiola algida against chronic hypoxia-induced pulmonary arterial hypertension and its anti-proliferation mechanism in rats.
    Nan X; Su S; Ma K; Ma X; Wang X; Zhaxi D; Ge R; Li Z; Lu D
    J Ethnopharmacol; 2018 Apr; 216():175-183. PubMed ID: 29325918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZD1611, an orally active endothelin-A receptor antagonist, prevents chronic hypoxia-induced pulmonary hypertension in the rat.
    Bialecki RA; Fisher CS; Abbott BM; Barthlow HG; Caccese RG; Stow RB; Rumsey J; Rumsey W
    Pulm Pharmacol Ther; 1999; 12(5):303-12. PubMed ID: 10545286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant negative mutation of the TGF-beta receptor blocks hypoxia-induced pulmonary vascular remodeling.
    Chen YF; Feng JA; Li P; Xing D; Zhang Y; Serra R; Ambalavanan N; Majid-Hassan E; Oparil S
    J Appl Physiol (1985); 2006 Feb; 100(2):564-71. PubMed ID: 16223981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ET-A receptor blockade on eNOS gene expression in chronic hypoxic rat lungs.
    Blumberg FC; Wolf K; Arzt M; Lorenz C; Riegger GA; Pfeifer M
    J Appl Physiol (1985); 2003 Feb; 94(2):446-52. PubMed ID: 12391096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats.
    Chen SJ; Chen YF; Opgenorth TJ; Wessale JL; Meng QC; Durand J; DiCarlo VS; Oparil S
    J Cardiovasc Pharmacol; 1997 Jun; 29(6):713-25. PubMed ID: 9234651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smooth Muscle Insulin-Like Growth Factor-1 Mediates Hypoxia-Induced Pulmonary Hypertension in Neonatal Mice.
    Sun M; Ramchandran R; Chen J; Yang Q; Raj JU
    Am J Respir Cell Mol Biol; 2016 Dec; 55(6):779-791. PubMed ID: 27438786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial ET(B) limits vascular remodelling and development of pulmonary hypertension during hypoxia.
    Kelland NF; Bagnall AJ; Morecroft I; Gulliver-Sloan FH; Dempsie Y; Nilsen M; Yanagisawa M; Maclean MR; Kotelevtsev YV; Webb DJ
    J Vasc Res; 2010; 47(1):16-22. PubMed ID: 19672104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired iNOS-sGC-cGMP signalling contributes to chronic hypoxic and hypercapnic pulmonary hypertension in rat.
    Xia XD; Xu ZJ; Hu XG; Wu CY; Dai YR; Yang L
    Cell Biochem Funct; 2012 Jun; 30(4):279-85. PubMed ID: 22290599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.